Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
This supplement, and the meeting on which it is based (Park Plaza, Vauxhall Road, London, 20th April 2016), were sponsored by Novartis. UK prescribing information for ranibizumab can be found at the end of the supplement. All authors received honoraria, contributed to the development of the manuscript, and retained final control of the content and editorial decisions. Medical writing assistance was provided by Steven Cartmell and Jackie Johnson of Novartis. Novartis have checked that the content was factually accurate, balanced and compliant with the Association of the British Pharmaceutical Industry Code of Practice.
